Hypoxia Depresses Synaptic Transmission in the Primary Motor Cortex of the Infant Rat-Role of Adenosine A 1 Receptors and Nitric Oxide.
Isabella ZironiGiorgio AicardiPublished in: Biomedicines (2022)
The acute and long-term consequences of perinatal asphyxia have been extensively investigated, but only a few studies have focused on postnatal asphyxia. In particular, electrophysiological changes induced in the motor cortex by postnatal asphyxia have not been examined so far, despite the critical involvement of this cortical area in epilepsy. In this study, we exposed primary motor cortex slices obtained from infant rats in an age window (16-18 day-old) characterized by high incidence of hypoxia-induced seizures associated with epileptiform motor behavior to 10 min of hypoxia. Extracellular field potentials evoked by horizontal pathway stimulation were recorded in layers II/III of the primary motor cortex before, during, and after the hypoxic event. The results show that hypoxia reversibly depressed glutamatergic synaptic transmission and neuronal excitability. Data obtained in the presence of specific blockers suggest that synaptic depression was mediated by adenosine acting on pre-synaptic A 1 receptors to decrease glutamate release, and by a nitric oxide (NO)/cGMP postsynaptic pathway. These effects are neuroprotective because they limit energy failure. The present findings may be helpful in the preclinical search for therapeutic strategies aimed at preventing acute and long-term neurological consequences of postnatal asphyxia.
Keyphrases
- nitric oxide
- preterm infants
- liver failure
- drug induced
- endothelial cells
- prefrontal cortex
- nitric oxide synthase
- respiratory failure
- hydrogen peroxide
- protein kinase
- depressive symptoms
- oxidative stress
- high glucose
- multidrug resistant
- electronic health record
- aortic dissection
- risk factors
- physical activity
- hepatitis b virus
- mesenchymal stem cells
- sleep quality
- angiotensin converting enzyme
- acute respiratory distress syndrome
- angiotensin ii
- blood brain barrier
- extracorporeal membrane oxygenation